#Amgen collaboration; BeiGene has China commercial rights. -Ensem collaboration; BeiGene has global rights. vDualityBio collaboration; BeiGene has global clinical, manufacturing, and commercialization rights. DLeads Biolabs collaboration; BeiGene has global research, development, and manufacturing rights, and exclusive commercialization rights outside of China. &Zymeworks/Jazz collaboration; BeiGene has exclusive development and commercialization rights in Asia (except Japan), Australia, and New Zealand. }Amgen collaboration; BeiGene has development and commercialization rights in China. 2In combination with Zanubrutinib. |May include anti-PD-1, anti-LAG3, anti-OX40, and HPK1 inhibitor.
Welcome to to BeOne
Medical Affairs
BeOne is intended for health care professionals in the United States for the purpose of scientific exchange. This site contains educational resources and information relating to BeOne medicines, therapeutic areas of interest, congress materials, and publications. This site may include information on products or indications under investigation that are currently not approved in the United States. BeOne does not recommend the use of its products other than as described in the approved prescribing information. This site does not contain medical advice and does not replace independent medical judgment.
Please visit beigene.com for more information.